Our high quality standards, established know-how and our leading market position coupled with our dominant and highly successful salesforce, supported by our strong relationships with the local scientific community, have made ELPEN the partner of choice for the Greek market.

We are open to work under different business models including:

  • In-licensing
  • Co-marketing
  • Co-promotion
  • Distribution
  • Local representation of international companies

Some of our collaborations include

ELPEN is always seeking for on/off patent originator or biosimilar products, for which Phase III clinical trials have been completed, and for which FDA or EMA marketing authorization procedures have started or will be starting shortly. We may also assess potential partnerships involving products already authorized and marketed in the Greek market, and last but not least we seek to work with companies that are not currently represented in Greece.

At present ELPEN's portfolio in its domestic markets includes Rx and OTC products from therapeutic areas such as:

  • Respiratory
  • Cardiovascular
  • Central Nervous System
  • Infections
  • Metabolic
  • Gastrointestinal
  • Musculoskeletal
  • HIV
  • Urology
  • Pediatrics
  • Women Healthcare

To find out more, please contact us at bdgen@elpen.gr